LOS ANGELES, April 07, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced that the Sequire Cannabis & Psychedelic Conference will occur on April 20th, 2022.
Register Here: https://cannabis-conference22.mysequire.com/
This 1-day virtual investor event will be held via SRAX’s Sequire Virtual Events platform on April 20th, 2022. Nearly nine million active small-cap investors have been invited to the event, which will feature over 25 Cannabis & Psychedelic companies hosting 25 minute presentations, alongside keynotes highlighting prominent names in these spaces.
The conference is one of many industry specific events that Sequire hosts for their budding investor community. See more here.
Event: 2022 Sequire Cannabis & Psychedelic Conference
Date: Wednesday, April 20th, 2022
Time: 9:00am ET – 4:00pm ET
Register Here: https://cannabis-conference22.mysequire.com/
“This our second annual Sequire Cannabis & Psychedelic Conference. We are delighted by the public companies joining the program this year and have some stimulating speakers rounding out our keynotes and panels. We recently launched new 1:1 feature updates to the Sequire Virtual Events platform, so we are looking forward to having our audience experience that too,” said Morgan Fogg, Vice President of Community & Events at SRAX.
Marijuana Company Of America Inc, Item 9 Labs, and Delic Corp. are the sponsors of this exciting event.
About SRAX
SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com.
Cautionary Statement Regarding Forward-Looking Information:
This news release contains “forward-looking statements” made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to future, not past, events and may often be identified by words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Specific risks and uncertainties that could cause our actual results to differ materially from those expressed in our forward-looking statements include risks inherent in our business, and our need for future capital. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in SRAX’s periodic reports filed with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2020, its Quarterly Reports on Form 10-Q as well as and in other reports filed with the SEC. We do not assume any obligation to update any forward-looking statements.
Contact
Bri Kelvin
Investors@srax.com
